Subcutaneous rituximab: a practical approach?

Lancet Oncol. 2014 Mar;15(3):254-5. doi: 10.1016/S1470-2045(14)70009-9. Epub 2014 Feb 10.

Author

Kensei Tobinai¹

Affiliation

¹ Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: ktobinai@ncc.go.jp.

PMID: 24521992
DOI: 10.1016/S1470-2045(14)70009-9

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived / pharmacokinetics*
Antineoplastic Agents / pharmacokinetics*
Female
Humans
Lymphoma, Follicular / drug therapy*
Male
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab